$HRGN SEC Filings

Filed On	Filing
25 Sep 2026	Form 4: He Junli, Director Received 683,725 shares by conversion ($718K) · Bought 361,905 shares ($380K) · Bought 6,725 shares ($14.5K)
14 Sep 2026	D
14 Sep 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities This Securities Purchase Agreement (this “Agreement”) is dated as of September 11, 2026, between Harvard Apparatus Regenerative Technology, Inc., a Delaware corporation (the “Company”), and Jerry (Junli) He, an individual and the Chief E...
13 Aug 2026	FORM 10-Q
11 Aug 2026	Form 4: He Junli, Director Granted 600,000 Nonqualified Stock Option (right to buy), time-based tranche · Granted 600,000 Nonqualified Stock Option (right to buy), performance-based
03 Aug 2026	8-K/A: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation On April 13, 2026, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into a loan arrangement with Junli He, the Chairman and Chief Executive Officer of the Company (the “Lender”), pursuant to which the Lender agreed...
03 Aug 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
24 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
13 May 2026	FORM 10-Q
28 Apr 2026	8-K: Regulation FD Disclosure
23 Apr 2026	Proxy statement: annual meeting on June 18, 2026 CEO pay $440K, down 66% · say-on-pay vote
15 Apr 2026	8-K: Termination of a Material Definitive Agreement
19 Mar 2026	FORM 10-K
06 Jan 2026	D
06 Jan 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
01 Dec 2025	Form 4: He Junli, Director Bought 3,000 shares ($5.1K)
07 Nov 2025	FORM 10-Q
01 Oct 2025	Form 4: He Junli, Director Bought 300 shares ($594)
24 Sep 2025	Form 4: He Junli, Director Bought 11,225 shares ($20.8K)
02 Sep 2025	Form 4: He Junli, Director Bought 4,050 shares ($6.97K)

Comments